secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-04-12T23:59:59+00:00
Accession:  0001753926-24-000721
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella eliminates Series A Preferred Stock designation after all shares converted to common
--------------------------------------------------------------------------------

- Filed Series A Elimination Certificate with Delaware Secretary of State on April 11, 2024.
- All previously issued Series A Preferred Stock converted into common stock; no shares outstanding.
- No further shares will be issued under the Series A designation.
- Certificate became effective immediately upon filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/0001753926-24-000721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/g084176_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-000721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer